Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Obulytix is 1.5% (average). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
4 mandates
2
active directors
Philipp MuellerDirectorLisa PatelDirector+2 in history
All directors & mandates Publicationslatest 19-12-2025
19
publications in the State Gazette1 director appointed, 1 resigningAll publications & acts Network & structure
1
connected companySee network & structure
Connections
1 connected companyParent · 455 subsidiaries · 9 locations
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.5%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
| Legal nameNL | Obulytix |
Registered office
Suzanne Tassierstraat 1 bus 3.4
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.